← Open Payments lookup

PAMALA MCGOWAN: Open Payments

NPI 1962019653 · MEXIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$326 in 15 payments from 8 companies in 2025. Trend: 2023 $82 · 2024 $101 · 2025 $326

Food & beverage: $326
CompanyPaymentsAmount
ABBVIE INC.4$99
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$48
GlaxoSmithKline, LLC.2$47
Novo Nordisk Inc2$44
Merck Sharp & Dohme LLC2$36
Lilly USA, LLC1$19
AstraZeneca Pharmaceuticals LP1$17
Axsome Therapeutics, Inc.1$16

Products named: VRAYLAR, CAPLYTA, TRELEGY ELLIPTA, Wegovy, VAXNEUVANCE, MOUNJARO, Ozempic, BREZTRI.

Industry payments across TX — which companies pay providers there.